Bonum Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $26.91M (Form D filed Apr 17, 2026). SEC Form D 0001898714-26-000001 (Apr 17, 2026)
  Evidence (1 event)

  • Apr 17, 2026 · SEC Form D 0001898714-26-000001
    Name of Issuer: Bonum Therapeutics, Inc.; CIK: 1898714; Address: Seattle, WA; Submission type: D; Filing date: 2026-04-17; Industry Group: Biotechnology; Date of First Sale: 2026-04-03; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 32301381; Total Amount Sold: 26907396; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals